triazoles has been researched along with Granulomatosis with Polyangiitis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Baird, R; Campbell, K; Crawford, LC; Davidson, N; Davies, J; Foroughi, F; Kidd, SE; Lynar, S; Meumann, EM; Tayal, V | 1 |
Fox, DA; Gladue, HS | 1 |
Friedland, JS; Ind, PW; Nogueira, EL; Salama, AD | 1 |
Hide, M; Kamegashira, A; Kan, T; Ooiwa, H; Takahagi, S; Yaguchi, T | 1 |
1 review(s) available for triazoles and Granulomatosis with Polyangiitis
Article | Year |
---|---|
Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Male; Mucormycosis; Northern Territory; Triazoles | 2020 |
3 other study(ies) available for triazoles and Granulomatosis with Polyangiitis
Article | Year |
---|---|
Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
Topics: Aged; Alkaline Phosphatase; Antifungal Agents; Arthralgia; Diagnosis, Differential; Disease Progression; Female; Granulomatosis with Polyangiitis; Hip Joint; Humans; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Mucormycosis may mimic disease relapse in Wegener's granulomatosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Male; Mucormycosis; Radiography, Thoracic; Recurrence; Treatment Outcome; Triazoles | 2010 |
Disseminated subcutaneous phaeohyphomycosis caused by Exophiala oligosperma in a patient with Wegener's granulomatosis.
Topics: Aged; Antifungal Agents; Biopsy; DNA, Fungal; Exophiala; Female; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Phaeohyphomycosis; Pyrimidines; Ribotyping; Risk Factors; Skin; Treatment Outcome; Triazoles; Voriconazole | 2013 |